ATE424838T1 - Aus calomeria amarnthoides gewonnene extrakte und deren therapeutische verwendung - Google Patents

Aus calomeria amarnthoides gewonnene extrakte und deren therapeutische verwendung

Info

Publication number
ATE424838T1
ATE424838T1 AT05821668T AT05821668T ATE424838T1 AT E424838 T1 ATE424838 T1 AT E424838T1 AT 05821668 T AT05821668 T AT 05821668T AT 05821668 T AT05821668 T AT 05821668T AT E424838 T1 ATE424838 T1 AT E424838T1
Authority
AT
Austria
Prior art keywords
calomeria
amarnthoides
therapeutic use
extracts obtained
compounds
Prior art date
Application number
AT05821668T
Other languages
English (en)
Inventor
Haaften Caroline Van
Original Assignee
Haaften Caroline Van
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2004907275A external-priority patent/AU2004907275A0/en
Application filed by Haaften Caroline Van filed Critical Haaften Caroline Van
Application granted granted Critical
Publication of ATE424838T1 publication Critical patent/ATE424838T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
AT05821668T 2004-12-23 2005-12-23 Aus calomeria amarnthoides gewonnene extrakte und deren therapeutische verwendung ATE424838T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2004907275A AU2004907275A0 (en) 2004-12-23 Therapeutic compounds
AU2005900353A AU2005900353A0 (en) 2005-01-28 Therapeutic compounds

Publications (1)

Publication Number Publication Date
ATE424838T1 true ATE424838T1 (de) 2009-03-15

Family

ID=35999608

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05821668T ATE424838T1 (de) 2004-12-23 2005-12-23 Aus calomeria amarnthoides gewonnene extrakte und deren therapeutische verwendung

Country Status (9)

Country Link
US (1) US7951406B2 (de)
EP (1) EP1843759B1 (de)
JP (1) JP2008535775A (de)
CN (1) CN101098692B (de)
AT (1) ATE424838T1 (de)
CA (1) CA2592162A1 (de)
DE (1) DE602005013299D1 (de)
ES (1) ES2324051T3 (de)
WO (1) WO2006067603A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2005052C2 (en) 2010-07-07 2012-01-10 Caroline Haaften Xanthanodien for the treatment of cancer.
NL2013217B1 (en) 2014-07-18 2016-07-14 Van Haaften Caroline New combination treatment for ovarian cancer.
NL2019035B1 (en) * 2017-06-08 2018-12-17 Van Haaften Caroline Method of producing EPD and analogues thereof
CN107955014B (zh) * 2017-11-10 2019-06-28 南阳师范学院 萘并呋喃酮类化合物及制备与在制备抗肿瘤药物中的应用
CN108864015A (zh) * 2018-08-28 2018-11-23 青海大学 一种具有治疗神经退行性疾病功效的化合物及药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008904A1 (en) * 1992-10-15 1994-04-28 Duke University Antifouling coating composition and method
EP1135119A4 (de) * 1998-11-12 2004-11-03 Alteon Inc Glukose- und lipidsenkende verbindungen
KR20040107185A (ko) 2003-06-13 2004-12-20 이상국 알란토락톤 또는 이소알란토락톤을 포함하는 암 또는염증질환 예방 및 치료용 조성물

Also Published As

Publication number Publication date
WO2006067603A1 (en) 2006-06-29
US20080233214A1 (en) 2008-09-25
CA2592162A1 (en) 2006-06-29
CN101098692A (zh) 2008-01-02
US7951406B2 (en) 2011-05-31
JP2008535775A (ja) 2008-09-04
ES2324051T3 (es) 2009-07-29
DE602005013299D1 (de) 2009-04-23
CN101098692B (zh) 2012-01-25
EP1843759B1 (de) 2009-03-11
EP1843759A1 (de) 2007-10-17

Similar Documents

Publication Publication Date Title
SE0302811D0 (sv) Novel compounds
EA200500203A1 (ru) Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат
TW200800999A (en) Novel compounds
BRPI0717266A2 (pt) Derivados de oxindol
NO20081160L (no) Benzimidazoltiofen forbindelser
EA201170703A1 (ru) Производные адамантилбензамида
BRPI0516488A (pt) azolidinonas de 1,5-naftiridina tendo atividade antiproliferativa de cdk1
TNSN08284A1 (en) Masking the taste of powders
EA200702529A1 (ru) Фунгицидная комбинация биологически активных веществ
ATE528290T1 (de) Spiroindolinon-derivate
BRPI0311189B8 (pt) composições farmacêuticas contendo polimorfo a de flibanserin, bem como seu uso
DE602006016449D1 (de)
ATE474463T1 (de) Kokumi-geschmackverbindungen und ihre verwendung
DE602006020295D1 (de) Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel
WO2007022947A3 (de) 5-ring-heteroaromaten-verbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren
TW200745039A (en) Isotopically substituted pantoprazole
WO2009018551A3 (en) Therapeutic compounds
ATE424838T1 (de) Aus calomeria amarnthoides gewonnene extrakte und deren therapeutische verwendung
UY28917A1 (es) Derivados de tetrahidroisoquinolilsulfonamidas composiciones farmaceuticas y su uso terapeutico
GB0502787D0 (en) Pharmaceuticlly active compounds, their manufacture, compositions containing them and their use
EP2452944A4 (de) Diphenylsulfidderivate und arzneimittel damit als wirkstoff
DOP2006000024A (es) Tiazolidinonas, su preparación y su uso como medicamento
WO2006078984A3 (en) Uses of methylphenidate derivatives
WO2008098077A3 (en) Substituted alkine derivatives as anti-cancer agents
MX2007004274A (es) Quinazolinilmetilentiazolinonas como inhibidores de cdk1.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties